Search
Now showing items 1-1 of 1
Contribution of de novo lipogenesis to the progression of nonalcoholic fatty liver disease
(University of Missouri--Columbia, 2020)
and the benefits of reducing flux through this pathway to improve liver health. Both dietary and pharmacologic approaches to reduce DNL should be the focus of future treatment of NAFLD....